JP2024112859A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024112859A5 JP2024112859A5 JP2024077300A JP2024077300A JP2024112859A5 JP 2024112859 A5 JP2024112859 A5 JP 2024112859A5 JP 2024077300 A JP2024077300 A JP 2024077300A JP 2024077300 A JP2024077300 A JP 2024077300A JP 2024112859 A5 JP2024112859 A5 JP 2024112859A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- months
- seq
- determined
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026031310A JP2026097906A (ja) | 2018-07-24 | 2026-02-27 | アルツハイマー病の治療及び予防方法 |
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702659P | 2018-07-24 | 2018-07-24 | |
| US62/702,659 | 2018-07-24 | ||
| US201862749614P | 2018-10-23 | 2018-10-23 | |
| US62/749,614 | 2018-10-23 | ||
| US201962824162P | 2019-03-26 | 2019-03-26 | |
| US62/824,162 | 2019-03-26 | ||
| US201962846902P | 2019-05-13 | 2019-05-13 | |
| US62/846,902 | 2019-05-13 | ||
| US201962874684P | 2019-07-16 | 2019-07-16 | |
| US62/874,684 | 2019-07-16 | ||
| JP2021503770A JP7541505B2 (ja) | 2018-07-24 | 2019-07-23 | アルツハイマー病の治療及び予防方法 |
| PCT/US2019/043067 WO2020023530A2 (en) | 2018-07-24 | 2019-07-23 | Methods of treatment and prevention of alzheimer's disease |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503770A Division JP7541505B2 (ja) | 2018-07-24 | 2019-07-23 | アルツハイマー病の治療及び予防方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026031310A Division JP2026097906A (ja) | 2018-07-24 | 2026-02-27 | アルツハイマー病の治療及び予防方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024112859A JP2024112859A (ja) | 2024-08-21 |
| JP2024112859A5 true JP2024112859A5 (cg-RX-API-DMAC7.html) | 2025-03-06 |
| JP7875901B2 JP7875901B2 (ja) | 2026-06-18 |
Family
ID=67551415
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503770A Active JP7541505B2 (ja) | 2018-07-24 | 2019-07-23 | アルツハイマー病の治療及び予防方法 |
| JP2024077300A Active JP7875901B2 (ja) | 2018-07-24 | 2024-05-10 | アルツハイマー病の治療及び予防方法 |
| JP2026031310A Pending JP2026097906A (ja) | 2018-07-24 | 2026-02-27 | アルツハイマー病の治療及び予防方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503770A Active JP7541505B2 (ja) | 2018-07-24 | 2019-07-23 | アルツハイマー病の治療及び予防方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026031310A Pending JP2026097906A (ja) | 2018-07-24 | 2026-02-27 | アルツハイマー病の治療及び予防方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210324056A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3826674A2 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7541505B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210039402A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118924896A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019309938B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3107370A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL310132B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021000778A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12021500006A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020023530A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| PT4121007T (pt) * | 2020-03-20 | 2025-09-25 | Eisai R&D Man Co Ltd | Formulações de anticorpo de protofibrila de péptido anti-beta amiloide de concentração alta e métodos de uso das mesmas |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| AU2021310926A1 (en) | 2020-07-23 | 2023-03-23 | Othair Prothena Limited | Anti-abeta antibodies |
| WO2022035758A1 (en) * | 2020-08-12 | 2022-02-17 | The Cleveland Clinic Foundation | Bace1 inhibitor treatment for suppressing cytokine storm |
| TW202300517A (zh) * | 2021-03-12 | 2023-01-01 | 美商美國禮來大藥廠 | 抗類澱粉β抗體及其用途 |
| WO2023111618A1 (en) * | 2021-12-17 | 2023-06-22 | Eisai R&D Management Co., Ltd. | Methods of using an anti-amyloid beta protofibril antibody and anti-tau antibody |
| WO2023114586A1 (en) * | 2021-12-17 | 2023-06-22 | Eisai R&D Management Co., Ltd. | Methods of using an anti-amyloid beta protofibril antibody and anti-tau antibody |
| KR20240142535A (ko) * | 2022-02-02 | 2024-09-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | P-tau181 수준을 사용한 치료 방법 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001268005A1 (en) | 2000-07-07 | 2002-01-21 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| MY169492A (en) * | 2006-03-23 | 2019-04-15 | Bioarctic Neuroscience Ab | Improved protofibril selective antibodies and the use thereof |
| AU2016208353B2 (en) * | 2007-10-17 | 2017-07-20 | Janssen Alzheimer Immunotherapy | Immunotherapy regimes dependent on ApoE status |
| JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| BRPI0906962B8 (pt) | 2008-01-18 | 2021-05-25 | Eisai R&D Man Co Ltd | composto de aminodiidrotiazina fundido |
| SI2448968T1 (sl) | 2009-06-29 | 2021-07-30 | Bioarctic Ab | Protitelesa, selektivna za protofibrile/oligomere na N-koncu skrajšanega amiloida-beta |
| WO2011106732A1 (en) * | 2010-02-25 | 2011-09-01 | Wyeth Llc | Pet monitoring of ab-directed immunotherapy |
| CN110655573B (zh) | 2010-02-26 | 2023-07-18 | 生命北极神经科学公司 | 原细纤维结合抗体及其治疗和诊断帕金森氏症、路易体痴呆和其他α-共核蛋白病的应用 |
| EP2665716B1 (en) | 2011-01-21 | 2017-03-08 | Eisai R&D Management Co., Ltd. | Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives |
| CN106661103B (zh) | 2014-07-10 | 2020-11-03 | 生命北极神经科学公司 | 改进的Aβ初原纤维结合抗体 |
| MA41115A (fr) * | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
| EP3405489A1 (en) * | 2016-01-20 | 2018-11-28 | Genentech, Inc. | High dose treatments for alzheimer's disease |
| WO2017194789A1 (en) * | 2016-05-13 | 2017-11-16 | Institut Pasteur | Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology |
| TWI735600B (zh) * | 2016-07-01 | 2021-08-11 | 美商美國禮來大藥廠 | 抗-N3pGlu類澱粉β肽抗體及其用途 |
| KR102630042B1 (ko) * | 2016-10-27 | 2024-01-29 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 알츠하이머병의 치료를 위한 항-a베타 원시섬유 항체 및 베타-세크레타제 bace1 억제제를 포함하는 조성물 |
-
2019
- 2019-07-23 WO PCT/US2019/043067 patent/WO2020023530A2/en not_active Ceased
- 2019-07-23 KR KR1020217005322A patent/KR20210039402A/ko active Pending
- 2019-07-23 CA CA3107370A patent/CA3107370A1/en active Pending
- 2019-07-23 AU AU2019309938A patent/AU2019309938B2/en active Active
- 2019-07-23 IL IL310132A patent/IL310132B2/en unknown
- 2019-07-23 CN CN202411217698.2A patent/CN118924896A/zh active Pending
- 2019-07-23 IL IL280315A patent/IL280315B2/en unknown
- 2019-07-23 EP EP19750196.8A patent/EP3826674A2/en active Pending
- 2019-07-23 JP JP2021503770A patent/JP7541505B2/ja active Active
- 2019-07-23 MX MX2021000778A patent/MX2021000778A/es unknown
- 2019-07-23 CN CN201980062781.8A patent/CN112805031A/zh active Pending
- 2019-07-23 US US17/250,448 patent/US20210324056A1/en active Pending
-
2021
- 2021-01-21 PH PH12021500006A patent/PH12021500006A1/en unknown
-
2024
- 2024-05-10 JP JP2024077300A patent/JP7875901B2/ja active Active
-
2025
- 2025-09-25 IL IL323583A patent/IL323583A/en unknown
-
2026
- 2026-02-27 JP JP2026031310A patent/JP2026097906A/ja active Pending
- 2026-06-24 AU AU2026204903A patent/AU2026204903A1/en active Pending